Search
Enlarge Text | Printable Version | Sitemap | Contact us
People
Upcoming Events
Title: Dr. Job Title: Innogen Co-Investigator Tel: +44 (0) 1908 858572 Fax: +44 (0) 1908 654825 Email: R.E.Hanlin@open.ac.uk Building: ESRC Innogen Centre, Development Policy and Practice Group, The Open University, Walton Hall, Milton Keynes, MK7 6AA Room Number:
Rebecca is Lecturer in Development Policy and Practice at the Open University. After completing a BSc (Hons) in Development Studies and Politics from the School of Oriental and African Studies, Rebecca worked in Tanzania and Nigeria. During this time in Africa she worked both in private industry and as a consultant for theUK’s Department for International Development (DFID) and the United Nations Children’s Fund (UNICEF) in the area of malaria prevention technologies and public-private partnerships.
Rebecca also holds an MSc (Econ) in Health Policy, Planning and Financing, a joint award from London School of Economics and London School of Hygiene and Tropical Medicine and an MSc (Res) in Science and Technology Studies from University of Edinburgh. Rebecca's PhD in Science and Technology Studies (University of Edinburgh) investigated a health innovation partnership and its capacity building activities in Kenya.
Rebecca Hanlin CV - Jul 09 (PDF 31.1kb)
Doctoral Thesis: Partnerships for vaccine development: building capacity to strengthen developing country health and innovation
Edited Books and Special Issues:
Chataway, J.C., Smith, J., Hanlin, R and Rossiello, A. (2007) International Journal of Technology Management and Sustainable Development, Vol.6, Issue 1 – special issue on vaccine R&D in developing countries
Hanlin, R. (2011) 'Evaluating Global Health Partnerships: Implications for Global Health Governance' in Williams, O. & Rushton S. (eds.) Global Health Partnerships and private foundations: new frontiers in health and health governance Routledge
Chataway, J.C., Chaturvedi, K., Hanlin, R., Mugwagwa, J.T., and Wield, D.V. (2009) 'Building the case for national systems of health innovation' In Kalua, F. et al (eds.) Science, Technology and Innovation for Public Health in Africa Johannesburg: NEPAD, Chapter 1
Chataway, J.C., Chaturvedi, K., Hanlin, R., Mugwagwa, J.T., and Wield, D.V. (2009) 'Technological Trends and Opportunities to Combat Diseases of the Poor in Africa' In Kalua, F. et al (eds.) Science, Technology and Innovation for Public Health in Africa Johannesburg: NEPAD, Chapter 2
Chataway, J.C. and Hanlin, R. (2008). 'Sustainable (vaccine) development: the International AIDS Vaccine Initiative (IAVI) and capacity building' In: Matlin, S. et al. (eds.) Health Partnerships Review.Geneva: Global Forum for Health Research, pp. 43–46
Chataway, J., Brusoni, S., Cacciatori, E., Orsenigo, L. and Hanlin, R. (2008) 'The International AIDS Vaccine Initiative (IAVI) in a changing landscape of vaccine development: a Public Private Partnership as knowledge broker and integrator' in Chataway, J.C., Mackintosh, M. and Wuyts, M. (eds.) Promoting innovation, productivity and industrial growth and reducing poverty: bridging the policy gap London: Routledge
Chataway, J.C., Hanlin, R., Mugwagwa, J. and Muraguri, L. (2011) 'Global health social technologies: Reflections on evolving theories and landscapes' Research Policy Vol. 39(10)
Hanlin, R. and Sutz, J. (2010) 'Embedded linkages between social policies and innovation policies' African Journal of Science, Technology and Innovation for Development Vol. 2 (3)
Hanlin, R. (2009) 'International Product Development Partnerships: Innovation for better health?' RECIIS Vol. 3(4), December 2009
Kaplinsky R., Chataway, J., Clark, N., Hanlin, B., Kale, D., Muraguri, L., Papaioannou, T., Robbins, P and Wamae, W. (2009) 'Below the Radar: What Does Innovation in Emerging Economies Have to Offer Other Low Income Economies?' International Journal of Technology Management & Sustainable Development, Vol.8, No.3, pp.177-197.
Hanlin, R.E. and Murguri, L. (2009) ‘Improving access to health technologies by the poor: the social context in Tanzanian bed net production and delivery’ International Journal of Technology Management & Sustainable Development, Vol.8, No.3, pp. 237 – 248
Chataway, J. and Hanlin, R. (2008) 'Sustainable (vaccine) development:the International AIDS Vaccine Initiative (IAVI) and capacity building', Health Partnerships Review p43-45
Hanlin, R. (2007) 'Knowledge capacity and sustainable development: The case of South African HIV vaccine development', International Journal of Technology Management and Sustainable Development, Vol.6, Issue 1, pp.55-66
Smith, J., Chataway, J., Rosiello, A. and Hanlin, R. (2007) 'Rethinking Vaccine R&D in Developing Countries', International Journal of Technology Management and Sustainable Development, Vol. 6, Issue 1, pp. 3-7
Chataway, J., Brusoni, S., Cacciatori, E., Orsenigo, L. and Hanlin, R. (2007) 'The International AIDS Vaccine Initiative (IAVI) in a Changing Landscape of Vaccine Development: A Public Private Partnership as Knowledge Broker and Integrator', European Journal of Development Research, Vol. 19(1), pp. 100-17
Hanlin, R., Chataway, J. and Smith, J. (2007) 'Global health public-private partnerships: IAVI, partnerships and capacity building', African Journal of Medicine and Medical Science, Vol.36, pp.69-75
Hanlin, R. (2006) 'Increasing knowledge flow by linking innovation and health – the case of SAAVI Genomics, Policy and Society, Vol. 2(3), pp. 37-43
Chataway, J.C., Hanlin, R., Smith, J. and Wield, D.V. (2007) 'Technological Trends and Opportunities to Combat Diseases of the Poor in Africa',
Hanlin, R. (2006) 'SAAVI Case Study and The 3 ‘C’s (Collaboration, Capacity and Capabilities): Linking Innovation Systems and Health Systems in Development', IKD Working Paper
Hanlin, R. (2006) 'Implications For Sustainable Health Systems Of Ppps At The Interface Of Science And Technology And Public Health Fields (42)' (wp42)
Chataway, J.C., Hanlin, R., Smith, J. (2005) Making Bioscience Related Health Innovations Work for the Poor Policy Brief for ESRC GENOMICS Forum
Hanlin, R. (2005) “Bioscience, health innovations and the poor: are public-private partnerships the answer?” Policy Paper for ESRC INNOGEN Centre
(2007) (with J.C. Chataway, K. Chaturvedi, J.T. Mugwagwa and D.V. Wield) Building the Case for National Systems of Health Innovation Report for the New Economic Partnership for Africa (NEPAD)
(2007) (with J.C. Chataway, K. Chaturvedi, J.T. Mugwagwa and D.V. Wield) Technological Trends and Opportunities to Combat Diseases of the Poor in Africa Report for the New Economic Partnership for Africa (NEPAD)
(2002) A Situational Analysis of the ITN market in Nigeria UNICEF, Nigeria Reviews:
(2007) Review of The Oxford Handbook of Innovation Jan Faberberg, David C. Mowery and Richard R. Nelson (2006) Oxford: Oxford University Press in International Journal of Technology Management and Sustainable Development, Spring Issue Vol. 6 (2). Page 165. ISSN 1474-2748
“Building capacity for integrated health solutions in developing countries” at Globelics 2010, Kuala Lumpar, November 2010.
“Evaluating Global Health Partnerships: Implications for Global Health Governance” at the International Studies Association Conference, New York, February 2009.
“International Product Development Partnerships: Innovation for better health?” at Globelics 2008, Mexico City, 22-24 September 2008.
“Creating Science and Technology for Neglected Diseases: The International AIDS Vaccine Initiative (IAVI) as a Social Technology Experiment” at the International Studies Association Conference, 26-29 March 2008, San Francisco.
Paper entitled “Success beyond science: Vaccine Innovation Partnerships and ‘invisible innovation'” at the ESRC Genomics Network conference, “Genomics and Society: Today’s Answers, Tomorrow’s Questions”, 25-26th October 2007, London, UK.
Organised and participated in the roundtable discussion, “Opening the Gates: New Institutions on Health and Development” at the Development Studies Association Conference, 18-20th September 2007, University of Sussex, Brighton.
Paper entitled “Public-Private Partnerships and Vaccine Development” at the ESRC Genomics Policy and Research Forum workshop, “Vaccines and the Problem of Political Will”, Thursday 19th July, 2007, University of Edinburgh.
Paper entitled “Culture eats strategy for breakfast”: blurring boundaries in clinical research” at Extending the Boundaries: New Directions in Sociology, Department of Sociology, City University, Friday 27th April 2007
Paper entitled “The International AIDS Vaccine Initiative (IAVI) as knowledge broker or integrator” at the DIME (Dynamics of Institutions and Markets in Europe) Workshop, “Instituting the Market Process: Innovation, Market Architectures”, 7-8th December 2006, Manchester, UK. Jointly organised by CRIC and LEM
Paper entitled “Towards more integrated and collaborative health programming through PPPs: the case of IAVI Kenya” at the American African Studies Association conference, Washington DC, 17-19 November 2005.
Presentation entitled “HIV vaccine development partnerships and capacity building: some useful conceptualisations” at the ESRC Genomics Forum Conference, Edinburgh, 21-23 September, 2005
Presentation entitled “Vaccine technology partnerships linking innovation and health systems” at the Post Graduate Forum on Genetics and Society Colloquium, Cardiff University, 31 August-2 September 2005
Paper entitled “Global health PPPs: IAVI, partnerships and Capacity building” at the International Workshop/Symposium on Health Related Biotechnology in Africa: Ethical, Legal and Social Implications (ELSI) of transfer and development, Ibadan, Nigeria, 4-6 April 2005
Refereed journal articles in press or submitted
Hanlin, R., Asif. R. and Rajan, R. “Helping Mothers and Children Thrive: empowering Indian communities” European Journal of Development Research (submitted)
Rebbecca is involved in the following innogen projects:
Rebecca’s work is in the area of innovation and development with a specific focus on health innovation and its implications for the provision of equitable healthcare. Her current research interests include: health product development public-private partnerships; the application of genomic technologies in the developing world; scientific research capacity strengthening; the intangibles of innovation; and the application of innovation systems concepts in developing world settings.
back
|
Printable Version |
Sitemap |
Contact us
.jpg)
